The relationship between IL-17A and IL-22 expression and clinical severity in patients with moderate/severe persistent allergic rhinitis

Publication date: Available online 18 December 2018

Source: American Journal of Otolaryngology

Author(s): Shaghayegh Shahsavan, Ashkan Pirayesh, Omid Zargari Samani, Hedayatollah Shirzad, Mohamad Ali Zamani, Soroush Amani, Seyyedeh Maryam Kazemi, Mandana Moghni, Fatemeh Deris, Nader Bageri, Loghman Salimzadeh, Ghadir Tavakoli, Mostafa Gholami Arjenaki

Abstract

Purpose

Several reactions leading to numerous effects are regulated by IL-22. However, the relationship between IL-22 and immunopathogensis of allergic rhinitis (AR) has been rarely investigated. The aim of the present study was to investigate the levels of IL-22 and IL-17A in AR patients and their association with clinical severity of persistent allergic rhinitis (PAR).

Materials and methods

Thirty mild persistent allergic rhinitis (M PAR) patients, thirty moderate/severe persistent allergic rhinitis (M/S PAR) patients, and thirty healthy controls were enrolled in this study. Local production of IL-22 and IL-17A in PAR patients and healthy controls' nasal mucosa was examined by immunohistochemistry (IHC) and real-time polymerase chain reaction (RT-PCR) techniques. Serum levels of IL-22, IL-17A, specific immunoglobulin E (sIgE), and total IgE (tIgE) in PAR patients and healthy controls were determined by ELISA. In addition, blood eosinophil, nasal eosinophils per field, and total nasal syndrome score (TNSS) were also assessed.

Results

In comparison with healthy controls, production of IL-22 and IL-17A in M/S PAR patients increased significantly. Furthermore, serum levels as well as the mean number of IL-22⁺ and IL-17A⁺ cells in nasal mucosa correlated with sIgE, nasal eosinophil count, and TNSS.

Conclusion

The results of the present study provide the first evidence that local production of IL-22 might be expressed in PAR patients. The expression of IL-22 and IL-17A, and their correlations with clinical parameters in PAR patients suggest the role of these cytokines in the events involved in the development of PAR.

https://ift.tt/2BrJ1PT